Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand
Clinical Infectious Diseases · 05.10.2023 · 77 (7) · 976-986
DOI: 10.1093/cid/ciad321 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 26.05.2023. Verfasst von Julien Coussement und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Cryptococcosis, Cryptococcus neoformans, Cryptococcus gattii, Meningitis. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Patients without human immunodeficiency virus (HIV) are increasingly recognized as being at risk for cryptococcosis. Knowledge of characteristics of cryptococcosis in these patients remains incomplete.
Methods
We conducted a retrospective study of cryptococcosis in 46 Australian and New Zealand hospitals to compare its frequency in patients with and without HIV and describe its characteristics in patients without HIV. Patients with cryptococcosis between January 2015 and December 2019 were included.
Results
Of 475 patients with cryptococcosis, 90% were without HIV (426 of 475) with marked predominance in both Cryptococcus neoformans (88.7%) and Cryptococcus gattii cases (94.3%). Most patients without HIV (60.8%) had a known immunocompromising condition: cancer (n = 91), organ transplantation (n = 81), or other immunocompromising condition (n = 97). Cryptococcosis presented as incidental imaging findings in 16.4% of patients (70 of 426). The serum cryptococcal antigen test was positive in 85.1% of tested patients (319 of 375); high titers independently predicted risk of central nervous system involvement. Lumbar puncture was performed in 167 patients to screen for asymptomatic meningitis, with a positivity rate of 13.2% where meningitis could have been predicted by a high serum cryptococcal antigen titer and/or fungemia in 95% of evaluable cases. One-year all-cause mortality was 20.9% in patients without HIV and 21.7% in patients with HIV (P = .89).
Conclusions
Ninety percent of cryptococcosis cases occurred in patients without HIV (89% and 94% for C. neoformans and C. gattii, respectively). Emerging patient risk groups were evident. A high level of awareness is warranted to diagnose cryptococcosis in patients without HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Microbiology, PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, Washington, Australia.
- Department of Infectious Diseases, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
- Department of Infectious Diseases, Royal Perth Hospital, Perth, Western Australia, Australia.
- Royal Adelaide Hospital, Adelaide, South Australia, Australia.
ORCID-Profile: Julien Coussement
Zitieren
APA
Coussement, J., Heath, C. H., Roberts, M. B., Lane, R. J., Spelman, T., Smibert, O. C., Longhitano, A., Morrissey, O., Nield, B., Tripathy, M., Davis, J. S., Kennedy, K. J., Lynar, S. A., Crawford, L. C., Crawford, S. J., Smith, B. J., Gador-Whyte, A. P., Haywood, R., Mahony, A. A., …, & Australian and New Zealand Study Group for Cryptococcosis in Patients Without HIV Infection (2023). Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand. Clinical Infectious Diseases, 77(7), 976-986. https://doi.org/10.1093/cid/ciad321
Vancouver
Coussement J, Heath CH, Roberts MB, Lane RJ, Spelman T, Smibert OC, et al. Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand. Clinical Infectious Diseases. 2023;77(7):976-986. doi:10.1093/cid/ciad321
BibTeX
@article{Coussement2023,
author = {Coussement, Julien and Heath, Christopher H and Roberts, Matthew B and Lane, Rebekah J and Spelman, Tim and Smibert, Olivia C and Longhitano, Anthony and Morrissey, Orla and Nield, Blake and Tripathy, Monica and Davis, Joshua S and Kennedy, Karina J and Lynar, Sarah A and Crawford, Lucy C and Crawford, Simeon J and Smith, Benjamin J and Gador-Whyte, Andrew P and Haywood, Rose and Mahony, Andrew A and Howard, Julia C and Walls, Genevieve B and O'Kane, Gabrielle M and Broom, Matthew T and Keighley, Caitlin L and Bupha-Intr, Olivia and Cooley, Louise and O'Hern, Jennifer A and Jackson, Justin D and Morris, Arthur J and Bartolo, Caroline and Tramontana, Adrian R and Grimwade, Katherine C and Au Yeung, Victor and Chean, Roy and Woolnough, Emily and Teh, Benjamin W and Chen, Sharon C A and Slavin, Monica A and Australian and New Zealand Study Group for Cryptococcosis in Patients Without HIV Infection, Australian and New Zealand Study Group for Cryptococcosis in Patients Without HIV Infection},
title = {Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {77},
number = {7},
pages = {976--986},
doi = {10.1093/cid/ciad321}
}
EUVIMED